{'fraction_non_alphanumeric': 0.018214936247723135, 'fraction_numerical': 0.0, 'mean_word_length': 5.7073170731707314, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Haemolysis secondary to intravenous immunoglobulins for ITP

Introduction Intravenous immunoglobulins (IVIGs) have been administered as a treatment for many autoimmune conditions including immune thrombocytopaenia (ITP). It provides a very good response in most patients with ITP and is usually associated with minor adverse effects including headache and infusional reactions. In this report, an unusual complication is described, which physicians should be aware of, when they use IVIG in high doses for the management of ITP and other conditions.